Creek Parent, Inc. and Creek Feeder, L.P.
Creek Parent, Inc. is the acquisition holding entity used by Novo Holdings A/S to take Catalent, Inc. private. Catalent is a contract development and manufacturing organization (CDMO) providing drug- and biologic-development, delivery, and manufacturing services to pharmaceutical and biotech customers. The Creek Parent / Creek Feeder financing structure backs the Catalent take-private.
Company profile compiled from public sources (company filings, rating-agency reports, and press releases) — distinct from the SEC Schedule-of-Investments pricing data below.
Lenders
Creek Parent, Inc. and Creek Feeder, L.P. is held by 5 BDC lenders in our parsed SEC filings: AGTC, ARCC, BXSL, GBDC, OBDC.
Cross-lender loan pricing
Each row is one debt tranche at the BDC’s most recent filing that holds this borrower, widest spread first. Mark is the position’s fair value as a percent of par (100 = par). Spread is shown in basis points over the benchmark in the Rate column, normalized from each filing’s as-reported units — rows quoting different benchmarks are still not directly comparable. Compare like-for-like: a second-lien tranche, a different vintage, or an older filing should price wider even when the credit view is identical — check the Type and Filing columns before reading a gap as disagreement. Source: SEC EDGAR (public).
| BDC | Type | Rate | Cash spread (bps) | Mark (% of par) | Fair Value | Maturity | Filing |
|---|---|---|---|---|---|---|---|
| AGTC | 1L Sr Secured | SOFR | 500 | 100.0 | $122M | 2031-12 | 2026-08-07 |
| ARCC | 1L Sr Secured | SOFR | 500 | 100.0 | $206M | 2031-12 | 2026-07-29 |
| BXSL | 1L Sr Secured | SOFR | 500 | 98.5 | $67M | 2031-12-18 | 2026-08-06 |
| GBDC | 1L Sr Secured | SOFR | 500 | 98.5 | $55M | 2031-12 | 2026-08-03 |
| OBDC | 1L Sr Secured | SOFR | 500 | 99.2 | $112M | 2031-12 | 2026-08-05 |
| AGTC | 1L Sr Secured | — | — | — | 2031-12 | 2026-08-07 | |
| ARCC | 1L Sr Secured | SOFR | — | — | — | 2031-12 | 2026-07-29 |
| GBDC | 1L Sr Secured | FIXED | — | — | -$121K | 2031-12 | 2026-08-03 |
| OBDC | 1L Sr Secured | — | — | -$123K | 2031-12 | 2026-08-05 |
Marks reflect each BDC’s own fair-value estimates as reported to the SEC, not traded prices. Private-credit loans are predominantly Level 3 under ASC 820 — valued from unobservable inputs and determined in good faith by each BDC’s board, so figures are estimates as of the filing date and are not directly comparable across managers. Informational only; not investment advice or a valuation.
Ownership & deal activity
Verified headlines that signal an acquisition, merger, buyout, sponsor change, refinancing, or restructuring involving Creek Parent, Inc. and Creek Feeder, L.P.. A mention is not confirmation of a completed deal — verify against the linked source. Source: Google News.
- Codis Completes Acquisition of Catalent's Nottingham, UK Facility, Expanding Europe's Premier Spray Dry Network
- Codis to Acquire UK Catalent Facility, Creating End-to-End Spray Drying Capabilities
- Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider
- Codis To Acquire Catalent's Nottingham, UK Facility to Create Europe's Leading End-to-End Spray Dry Capability
Headlines mentioning Creek Parent, Inc. and Creek Feeder, L.P.
Public headlines that name Creek Parent, Inc. and Creek Feeder, L.P., matched by company name and shown most-recent first. A mention is not an endorsement, a rating, or investment advice — verify anything material against the original source. Source: Google News.
- Scholar Rock shifts apitegromab BLA to second fill-finish site after Catalent FDA inspection
- Novo’s Catalent plant ditched in FDA refiling of SMA drug
- Scholar Rock drops Catalent facility from marketing application for muscle weakness drug
- Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
- Taysha Gene Therapies and Catalent Expand Strategic
- Codis Completes Acquisition of Catalent's Nottingham, UK Facility, Expanding Europe's Premier Spray Dry Network
- Alessandro Maselli, President and CEO of Catalent
- Codis to Acquire UK Catalent Facility, Creating End-to-End Spray Drying Capabilities
Reading this table
When two business development companies lend to the same borrower, comparing how each marks the loan is a starting question, not a verdict. In plain English: a wider spread (e.g. S+575 vs S+525) or a lower mark (e.g. 96 vs 100 cents on the dollar) can mean that lender is pricing in more risk — but marks can also differ for reasons other than a credit view: a different tranche (second lien should price wider than first lien on the same company), a different vintage or entry point, an older filing date, or each manager’s own fair-value methodology. Compare like-for-like — check the Type and Filing columns before reading a gap as disagreement. Each row is one debt position at one BDC’s most recent filing. Source: SEC EDGAR Schedule of Investments (public).
Want to read these numbers like an analyst? Free Oxford Ledge lessons: reading a BDC’s Schedule of Investments, key credit metrics, and the Five Cs of credit analysis.